MarketPulse

net loss improvement

2 articles
BenzingaBenzinga··Prnewswire

KLYG Cuts Losses 85% Despite Revenue Dip, Secures FDA Win for Fusion Implants

$KLYG reported 85% net loss improvement to $138.6K on $3.05M revenue, secured FDA clearance for Fusion™ cranial implants, rejected acquisition offer.
KLYGFDA clearancenet loss improvement
GlobeNewswire Inc.GlobeNewswire Inc.··Aligos Therapeutics, Inc.

Aligos Therapeutics Cuts Losses 82% While Advancing Hepatitis B Pipeline

Aligos reports $24.2M net loss in 2025, down 82% YoY. Key hepatitis B study enrollment complete; cash runway extends to Q3 2026.
ALGSPhase 2 clinical trialfinancial results